| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |